GO
Loading...

Macke: Playing Defense

Thursday, 17 Jan 2008 | 4:48 PM ET


You might have to accept that we’re in a bear market and Ben Bernanke can’t save it, Jeff Macke said on Thursday’s Closing Bell. But that doesn’t mean there aren’t buying opportunites - investors just need to be picky.

Fast Money: Playing Defense
While the drug companies are beaten down, there might be some opportunities. Fast Money's Jeff Macke shares his investment strategy.

Jeff’s plan is to stay defensive. He recommended Merck , down a sharp 5% on negative news about its drug Vytorin. Big Pharma names are traditionally defensive and a beaten-down Merck is Jeff’s favorite for right now.

______________________________________________________
Got something to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to fastmoney@cnbc.com.

  Price   Change %Change
MRK
---

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET
  • Melissa Lee is the host of CNBC's “Fast Money” and “Options Action.”

  • Scott Wapner is host of the "Fast Money Halftime Report," which airs weekdays from 12 p.m. to 1 p.m. ET.

  • Guy Adami is a contributor on CNBC's "Fast Money." He also is managing director of stockMONSTER.com.

  • Najarian, the "Pit Boss," is cofounder of optionMONSTER.com, a news site for options traders.

  • Finerman is president of Metropolitan Capital Advisors, Inc., a company she co-founded.

  • Founder of EmergingMoney.com

  • Chief Market Strategist for Virtus Investment Partners & CNBC Contributor

Halftime Report